35 related articles for article (PubMed ID: 15300811)
1. Male breast cancer differs from female breast cancer in molecular features that affect prognoses and drug responses.
Li Y; Guo Y; Chen F; Cui Y; Chen X; Shi G
Transl Oncol; 2024 May; 45():101980. PubMed ID: 38701649
[TBL] [Abstract][Full Text] [Related]
2. HER2 Low Expression in Primary Male Breast Cancer.
Nobbe K; Erices-Leclercq M; Foerster F; Förster R; Baldus SE; Rudlowski C; Schröder L; Lubig S
Breast Cancer (Dove Med Press); 2024; 16():141-148. PubMed ID: 38562651
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the Clinical Advancements for
McClurg DP; Urquhart G; McGoldrick T; Chatterji S; Miedzybrodzka Z; Speirs V; Elsberger B
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804947
[TBL] [Abstract][Full Text] [Related]
4. Genetic Landscape of Male Breast Cancer.
Campos FAB; Rouleau E; Torrezan GT; Carraro DM; Casali da Rocha JC; Mantovani HK; da Silva LR; Osório CABT; Moraes Sanches S; Caputo SM; Santana Dos Santos E
Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298749
[TBL] [Abstract][Full Text] [Related]
5. Lobular Breast Cancer in a Male Patient with a Previous History of Irradiation Due to Hodgkin's Disease.
Ninkovic S; Azanjac G; Knezevic M; Radovanovic D; Canovic D; Nedovic J; Mitrovic S
Breast Care (Basel); 2012 Aug; 7(4):315-8. PubMed ID: 23904835
[TBL] [Abstract][Full Text] [Related]
6. Inherited and acquired alterations in development of breast cancer.
Rizzolo P; Silvestri V; Falchetti M; Ottini L
Appl Clin Genet; 2011; 4():145-58. PubMed ID: 23776375
[TBL] [Abstract][Full Text] [Related]
7. Wip1 and p53 contribute to HTLV-1 Tax-induced tumorigenesis.
Zane L; Yasunaga J; Mitagami Y; Yedavalli V; Tang SW; Chen CY; Ratner L; Lu X; Jeang KT
Retrovirology; 2012 Dec; 9():114. PubMed ID: 23256545
[TBL] [Abstract][Full Text] [Related]
8. Expression pattern of ATM and cyclin D1 in ductal carcinoma, normal adjacent and normal breast tissues of Iranian breast cancer patients.
Salimi M; Mozdarani H; Majidzadeh K
Med Oncol; 2012 Sep; 29(3):1502-9. PubMed ID: 21850541
[TBL] [Abstract][Full Text] [Related]
9. Mucinous breast carcinoma presenting as Paget's disease of the nipple in a man: a case report.
Peschos D; Tsanou E; Dallas P; Charalabopoulos K; Kanaris C; Batistatou A
Diagn Pathol; 2008 Oct; 3():42. PubMed ID: 18950495
[TBL] [Abstract][Full Text] [Related]
10. Suppressor of cytokine signalling 2 (SOCS-2) expression in breast carcinoma.
Farabegoli F; Ceccarelli C; Santini D; Taffurelli M
J Clin Pathol; 2005 Oct; 58(10):1046-50. PubMed ID: 16189149
[TBL] [Abstract][Full Text] [Related]
11. Cyclin DI amplification is not associated with reduced overall survival in primary breast cancer but may predict early relapse in patients with features of good prognosis.
Seshadri R; Lee CS; Hui R; McCaul K; Horsfall DJ; Sutherland RL
Clin Cancer Res; 1996 Jul; 2(7):1177-84. PubMed ID: 9816285
[TBL] [Abstract][Full Text] [Related]
12. Male breast cancer is not congruent with the female disease.
Fentiman IS
Crit Rev Oncol Hematol; 2016 May; 101():119-24. PubMed ID: 26989051
[TBL] [Abstract][Full Text] [Related]
13. ERBB2 oncogene in human breast cancer and its clinical significance.
Révillion F; Bonneterre J; Peyrat JP
Eur J Cancer; 1998 May; 34(6):791-808. PubMed ID: 9797688
[TBL] [Abstract][Full Text] [Related]
14. Frequent amplification and overexpression of CCND1 in male breast cancer.
Bärlund M; Kuukasjärvi T; Syrjäkoski K; Auvinen A; Kallioniemi A
Int J Cancer; 2004 Oct; 111(6):968-71. PubMed ID: 15300811
[TBL] [Abstract][Full Text] [Related]
15. [Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection].
Mrhalová M; Kodet R; Strnad P
Cas Lek Cesk; 2002 Nov; 141(22):708-14. PubMed ID: 12532908
[TBL] [Abstract][Full Text] [Related]
16. High CCND1 amplification identifies a group of poor prognosis women with estrogen receptor positive breast cancer.
Roy PG; Pratt N; Purdie CA; Baker L; Ashfield A; Quinlan P; Thompson AM
Int J Cancer; 2010 Jul; 127(2):355-60. PubMed ID: 19904758
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
